Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Research analysts at KeyCorp decreased their Q3 2017 EPS estimates for shares of Acadia Healthcare in a research note issued on Tuesday. KeyCorp analyst J. Gurda now expects that the company will post earnings per share of $0.63 for the quarter, down from their previous forecast of $0.66. KeyCorp also issued estimates for Acadia Healthcare’s Q4 2017 earnings at $0.66 EPS.
Other analysts also recently issued research reports about the stock. Mizuho increased their target price on shares of Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Craig Hallum reissued a “buy” rating and set a $65.00 target price (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Deutsche Bank AG increased their target price on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, July 31st. UBS AG reissued a “positive” rating and set a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Finally, Zacks Investment Research downgraded shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $56.91.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2017/10/28/keycorp-weighs-in-on-acadia-healthcare-company-inc-s-q3-2017-earnings-achc.html.
Acadia Healthcare (NASDAQ ACHC) opened at 42.27 on Thursday. Acadia Healthcare has a 12-month low of $32.54 and a 12-month high of $54.34. The company has a market capitalization of $3.71 billion, a P/E ratio of 464.51 and a beta of 1.07. The stock’s 50 day moving average is $45.77 and its 200-day moving average is $46.31.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. The company had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm’s revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period last year, the firm earned $0.73 EPS.
In other news, Director William Grieco sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $51.71, for a total transaction of $103,420.00. Following the completion of the sale, the director now owns 45,013 shares of the company’s stock, valued at approximately $2,327,622.23. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Reeve B. Waud sold 1,240,000 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $51.72, for a total transaction of $64,132,800.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 3,085,693 shares of company stock valued at $157,729,099. Insiders own 11.10% of the company’s stock.
Several hedge funds have recently made changes to their positions in the company. UBS Asset Management Americas Inc. lifted its holdings in shares of Acadia Healthcare by 21.6% in the 1st quarter. UBS Asset Management Americas Inc. now owns 332,355 shares of the company’s stock worth $14,491,000 after purchasing an additional 59,001 shares in the last quarter. FMR LLC lifted its holdings in shares of Acadia Healthcare by 173.2% in the 1st quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after purchasing an additional 1,391,552 shares in the last quarter. Teachers Advisors LLC lifted its holdings in shares of Acadia Healthcare by 1.3% in the 1st quarter. Teachers Advisors LLC now owns 373,571 shares of the company’s stock worth $16,288,000 after purchasing an additional 4,886 shares in the last quarter. Royce & Associates LP bought a new position in shares of Acadia Healthcare in the 1st quarter worth $4,361,000. Finally, Legal & General Group Plc lifted its holdings in shares of Acadia Healthcare by 226.4% in the 1st quarter. Legal & General Group Plc now owns 25,756 shares of the company’s stock worth $1,123,000 after purchasing an additional 17,865 shares in the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.